| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.16 | 0.4 |